Replies to post #23311 on Mymetics Corp (MYMX)

[Work Harder]

Jean Paul Rohmer Director Business Development

joined Anergis in 2009
since 2000 Managing Director IDEFI Gestion (Advice and interim management for biotechs and for biotech investors)
1994-1999 CEO Stallergenes SA, France
1979-1994 Eli Lilly Pharma France, Head of Pharma Division in the last two years

Vast experience in Pharma and biotech management, marketing as well as specifcally in allergen immmunotherapy while at Stallergenes

Esperante Ventures, Defi Gestion/Initiative Capital Romandie

https://gust.com/companies/anergis

Esperante BV

Siriusdreef 22 2132 WT
Hoofddorp
The Netherlands

Esperante Ltd.

Drayton Hall, Church Road
West Drayton, UB7 7PS
United Kingdom

https://www.esperanteventures.com/portfolio-clients/

DEFI Gestion

Exits

Kuros Biosciences

https://www.crunchbase.com/organization/defi-gestion/recent_investments

https://pitchbook.com/profiles/investor/14185-36#overview

The web host www.defigestion.ch does not exist.

Rainbows & Unicorns LOL

https://unicorn-nest.com/funds/defi-gestion/

Anergis new headquarters

Geneva

Da WHO

Umbrella AG

:}

[Phosphene]

Chris Viehbacher.

Check history on Ernesto's hand picked leader at Gurnet Point:

https://www.gurnetpointcapital.com/team/christopher-viehbacher

https://www.fiercebiotech.com/biotech/chris-viehbacher-explains-if-i-had-2-billion-to-invest%E2%80%A6

https://www.forbes.com/sites/matthewherper/2014/10/29/dear-sanofi-firing-ceo-chris-viehbacher-is-a-huge-mistake/?sh=70664dc675c0